What in the World?!
MOA
THE NAKED TRUTH
HOW CAN WE HELP
100

This amount of Librela doses have been dispensed around the world since 2021.

14 Million

Bonus: 18 Million

100

This body part is most associated with OA pain

Joint

100

Librela was well tolerated at this many times the label dose.

10X

100

This percentage of pet owners accept their veterinarians OA pain recommendation.

What is 90%

200

What percent of European Veterinarians used Librela as the main OA treatment for canine patients, with no other pharmaceutical intervention required?

75%

200

Librela specifically targets this within the body

Nerve Growth Factor (NGF)

200

Any remaining liquid from a punctured vial must be discarded right away and not used twice, why?

There is no preservative in Librela.

200

Booking the follow up appointment for Librela/ Solensia may best be done during this time for best compliance.

During the visit/ before leaving your hospital (91% of patients returned for a next visit when booked before leaving the practice.)

300

In the EU field study, how many days did it take for the placebo group to notice no improvement?

56

300

Librela is this type of therapy

Anti- NGF Monoclonal Antibody (mAb)

300

This is the age limit for dogs to receive Librela?

Not specified: Recommended 12 month of age and older.

300

OA pain effects dogs and cats at any age, yet the average age at diagnosis remains ____ years for dogs and ____ years for cats.

10.4; 12.7

400

This % of Librela is being used for patients with only mild to moderate (aka first line) OA pain.

What is 36%-37%

400

True or False: unlike cats, Canine OA is a secondary disease

True

400

You need to confirm this diagnosis before using Librela in dogs?

Osteoarthritis

400

Using the validated OA screening tool you can help control ______ % more dogs and ______% more cats pain sooner than ever before.

18% more dogs; 36% more cats 

(20% -> 38%; 3 -> 39%)

500
This is the recommendation in the most recent WSAVA and AAHA guidelines for first line treatment in the recognition, assessment and treatment of pain.

anti-NFG mAb or NSAIDs

500

True or False: Librela not only controls but inflammation since Nerve growth factor (NGF) contributes to vicious inflammation and pain by binding to the TrkA receptor on inflammatory cells. By controlling NGF you also control the inflammation.

True

500

Though rare (.01%-.1% adverse event), if you were to see an adverse event in Librela it would fall into these 3 categories according to the label.

UTI, bacterial skin infections, or dermatitis

500

This is the age in dogs and cats that Ambassador Long Beach Animal Hospital will begin creating OA pain awareness and screening for our patients.

?